Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0P3IZ
|
||||
Former ID |
DIB007231
|
||||
Drug Name |
E-2040
|
||||
Indication | Schizophrenia [ICD9: 295; ICD10:F20] | Terminated | [546598] | ||
Company |
Eisai Co Ltd
|
||||
Structure |
Download2D MOL |
||||
Canonical SMILES |
c1(c(c(cc(N2CCN(CC2)CCO)c1)[C@H](F)CC)Cl)c1c(C#N)cccc1.<br />Cl
|
||||
CAS Number |
CAS 172732-21-7
|
||||
Target and Pathway | |||||
Target(s) | 5-HT 2 receptor | Target Info | Modulator | [546599] | |
D(3) dopamine receptor | Target Info | Modulator | [546599] | ||
D(2) dopamine receptor | Target Info | Modulator | [546599] | ||
KEGG Pathway | Calcium signaling pathway | ||||
Neuroactive ligand-receptor interaction | |||||
Gap junction | |||||
Serotonergic synapse | |||||
Inflammatory mediator regulation of TRP channelshsa04080:Neuroactive ligand-receptor interaction | |||||
Dopaminergic synapsehsa04015:Rap1 signaling pathway | |||||
cAMP signaling pathway | |||||
Dopaminergic synapse | |||||
Parkinson's disease | |||||
Cocaine addiction | |||||
Alcoholism | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.